Business is booming for Emergent BioSolutions as it has assisted in the country’s push to create COVID-19 treatments and vaccines. Emergent is developing two plasma-based treatments for COVID-19 and has partnered with four companies on vaccine candidates. It is additionally partnering with the Federal Government to develop and manufacture COVID-19 vaccines. As a result of this wave of new business, the company is hiring approximately 300 new employees in Baltimore and Rockville.
{iframe}https://www.southbmore.com/2020/06/18/emergent-biosolutions-adding-approximately-300-jobs-after-new-covid-19-vaccine-contracts/{/iframe}